Research projects

Our goal is to improve the treatment and care of the individual patient and to reduce the burden of cardiovascular disease - for the patient and the community.

We conduct research projects in the following areas:

Cardiovascular Disease incidence and long term follow up in national and international clinical registries

  • Epidemiological registry and cohort studies including:
    • SWEDEHEART projects
    • EUROHEART projects
    • RIKSSVIKT projects

Registry based randomized clinical trials (R-RCT) to evaluate and implement cardiac care and treatments

  • HELP – Cluster R-RCT on Helicobacter pylori screening in patients with myocardial infarction
  • DAPA-MI – R-RCT on Dapagliflozin in individuals with a myocardial infarction, and normal ejection fraction of the heart
  • INFINITY-SWEDHEART – R-RCT on comparing long term outcomes of the DynamX Bioadaptor to the Resolute Onyx coronary stents
  • MINOCA-BAT – optimal medical treatment in patients with MINOCA
  • REDUCE-SWEDEHEART – Betablockers in patients with a myocardial infarction, and normal ejection fraction of the heart

Diagnosis, risk assessment and individualized treatment

  • Biomarker substudies – in several national and international clinical cohorts
  • The ABC-AF project – A study for increased understanding and risk assessment of individuals with atrial fibrillation – including a prospective trial of risk assessment using the ABC-AF risk tool

Pathophysiological studies on imaging and mechanistic studies

  • DAPA-CARD - Advanced cardiac imaging of individuals on dapagliflozin treatment
  • LV- REGURGE study – A study on long term follow up of Mitral Regurgitation and LV function

Evaluation of new (but also clinically available) therapies

  • International pharmaceutical trials – we lead, or take part in, several randomized clinical trials.
  • Registry based randomized clinical trials (R-RCT) within the framework of SWEDEHEART and other registries

Observational registry and cohort studies

Last modified: 2022-08-19